Table 1—

Characteristics of study population

CharacteristicsPercentage of enrollees
n900
Age (years)
    <4519.7
    45–5438.5
    55–6432.9
    ≥658.9
Sex
    Male55.2
    Female44.8
Single versus multiple oral therapy in 2000
    Multiple therapies45.8
    Single therapy54.2
Nonadherence to medications in 2000 (MPR <80%)
    Antihyperglycemic28.8
    Antihypertensive18.8
    Lipid-modifying26.9
Charlson comorbidity index
    167.1
    2–325.3
    ≥47.6
Hospitalizations
    2000 (all cause)11.4
    2001 (diabetes/CVD)*6.7
  • *

    * CVD represents both cardiovascular and cerebrovascular events.